Poultry Pharmaceuticals Market Expansion Supported by Increasing Zoonotic Disease Awareness

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Poultry Pharmaceuticals Market- (By Product Type (Drugs (Vetrimoxin, Other drug products), Vaccines (Innovax, Nobilis, Poulvac, Other vaccine products), Feed Additives (VIGOSINE, Amnovit, Other feed additives)), By Animal Type (Chicken, Turkey, Duck, Goose, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Poultry Pharmaceuticals Market is valued at US$ 6.72 Bn in 2022, and it is expected to reach US$ 14.03 Bn by 2031, with a CAGR of 8.68% during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2142

Poultry pharmaceuticals comprise a broad spectrum of products designed to maintain and improve the health of domesticated birds, including chickens and turkeys. These products include vaccines for disease prevention, antibiotics for the treatment of infections, and other therapeutic agents addressing various health conditions in poultry. Administration of these pharmaceuticals is typically conducted under veterinary supervision to ensure animal welfare and compliance with food safety standards.

Research and development within the sector is heavily focused on the creation of both therapeutic and prophylactic vaccines targeting viral infections in poultry. These vaccines are delivered through multiple routes, including nasal, oral, ocular, in vivo, subcutaneous, and intramuscular methods. The poultry pharmaceutical market also encompasses feed additives and specialized formulations for the management of reproductive, metabolic, and infectious disorders. Such interventions are vital for optimizing both the health and productivity of poultry populations.

Market growth is being driven by increasing corporate investment in the development of innovative products that align with rising consumer demand for safe and healthy poultry. The emphasis on advancing vaccine technologies to prevent infectious diseases is a significant contributor to market expansion. Additionally, ongoing activities by leading industry players, particularly in vaccine development and regulatory approvals, are expected to further stimulate growth.

Nevertheless, the market faces certain challenges. The segment for inactivated vaccines is projected to experience slower growth due to regulatory recalls and compliance measures. Furthermore, factors such as limited product exclusivity, intense competition from generic alternatives, and stringent regulatory requirements may pose constraints to overall market expansion.

List of Prominent Players in the Poultry Pharmaceuticals Market:
• Aervoe Industries Inc.
• Bayer AG,
• Bimeda
• Ceva Sante Animale
• Elanco Animal Health (Eli Lilly and Company)
• Merck Animal Health
• Merial Animal Health (Sanofi)
• Virbac
• Boehringer Ingelheim
• Zoetis, Inc.
• Pacific GeneTech
• Avivagen Inc.
• Hester Biosciences Limited
• Venkys India
• Calier
• KM Biologics
• Others

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics: Poultry Pharmaceuticals
Drivers:
The global poultry pharmaceuticals market is projected to witness substantial growth during the forecast period, driven by rising poultry consumption-particularly chicken-and the increasing scale of poultry production, which includes chickens, ducks, turkeys, and geese for both meat and egg production. Poultry farming is a critical component of the global agricultural sector, and the poultry pharmaceuticals market has grown rapidly over recent decades, becoming a significant contributor to the global economy. Key factors fueling market expansion include the growing prevalence of zoonotic diseases in poultry and the rising demand for poultry-derived food products. The increasing incidence of such diseases has particularly reinforced the demand for effective pharmaceutical interventions.

Challenges:
The market faces several challenges that could impede growth. Limited awareness of poultry pharmaceuticals in emerging markets may slow adoption, while lockdowns and social restrictions in these regions have further impacted market expansion. Additional constraints include low product exclusivity, intense competition from generics, and stringent regulatory requirements. Moreover, the high cost of poultry pharmaceuticals, potential environmental concerns associated with chemical-based interventions, and complexities in production processes may restrict revenue growth over the forecast period.

Regional Trends:
North America is anticipated to maintain a dominant position in the global poultry pharmaceuticals market, supported by advanced technological infrastructure and the presence of established industry leaders. The region's growth is further driven by government initiatives promoting animal health and advancements in poultry husbandry practices, particularly the increasing demand for vaccines.

Europe also holds a significant market share, supported by higher investments in animal healthcare and steady growth in poultry product consumption. Strategic collaborations among leading market participants and ongoing innovation are expected to create additional growth opportunities across both regions, reinforcing the global expansion of the poultry pharmaceuticals market.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2142

Recent Developments:
• In April 2022, Ceva Santé Animale has recently disclosed the establishment of a collaborative enterprise in Japan with Mitsui. The primary objective of the newly established joint venture was to enhance Ceva's corporate reputation and business strategy with prospective Japanese partners. This facilitated Ceva's substantial expansion in Japan at an expedited pace.
• In Aug 2022, Bimeda, an animal health distributor, has just acquired Afrivet, a veterinary pharmaceutical firm. This acquisition has resulted in Bimeda currently possessing the most extensive presence among all animal health companies operating in Africa.

Segmentation of Poultry Pharmaceuticals Market-
By product type -
• Drugs
o Vetrimoxin
o Other drug products
• Vaccines
o Innovax
o Nobilis
o Poulvac
o Other vaccine products
• Feed Additives -
o VIGOSINE
o Amnovit
o Other feed additives
By Animal Type -
• Chicken
• Turkey
• Duck
• Goose
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/poultry-pharmaceuticals-market/2142

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.